ADVANCES

Virginia Commonwealth University

Richmond, VA,
United States

Kelly Gwathmey is originally from Richmond, Virginia. She studied neuroscience and behavioral biology at Emory University in Atlanta, Georgia. She then attended Eastern Virginia Medical School in Norfolk, Virginia. Her neurology and clinical neurophysiology training was completed at the University of Virginia. Following this, she completed a neuromuscular medicine fellowship at both Brigham and Women’s Hospital and Massachusetts General Hospital in Boston, Massachusetts. At the University of Virginia, she started the multidisciplinary MDA clinic, was co-director of the ALS clinic, and was the fellowship director for both the neuromuscular and clinical neurophysiology fellowships. She joined Virginia Commonwealth University in January 2019 and currently serves in the capacity of associate professor of neurology, neuromuscular division chair, neuromuscular medicine program director, and EMG laboratory director. Dr. Gwathmey sees a wide spectrum of neuromuscular patients and performs electrodiagnostic studies (nerve conduction studies and electromyography). Her research interests include quality-of-life instruments and autoimmune neuromuscular disorders.

Disclosures

Speakers Bureau/honoraria for non-CME: Alexion pharmaceuticals, argenx

Consultant/advisory board: Alexion pharmaceuticals, Amgen, argenx, UCB

Oxford Children’s Hospital

Oxford,
United Kingdom

Sithara Ramdas is a Consultant Paediatric Neurologist based at the Oxford Children’s Hospital and an Honorary Senior Clinical Lecturer with the University of Oxford. Her specialist interests are neuromuscular disorders and neuroimmunology. She leads the regional Paediatric Neuromuscular multi-disciplinary service. She is the Paediatric lead for the National Highly Specialised Services for Congenital Myasthenia Syndromes and Neuromyelitis Optica. She leads the Highly Specialised Service for Paediatric Multiple Sclerosis and NHS England Rare Disease Collaborative Network (RDCN) for Juvenile Myasthenia Gravis. She is the principal investigator for several past and current clinical trials and her current areas of research interest are on Duchenne muscular dystrophy (DMD), spinal muscular atrophy (SMA), Congenital and Acquired Myasthenia.

Disclosures

Speakers bureau/honoraria for non-CME: Roche

Consultant/advisory board: Italfarmaco, Pfizer, Roche

Educational grants: Biogen, Novartis, Roche